These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3805272

  • 1. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
    Sturk A, Schaap MC, ten Cate JW, Heymans HS, Schutgens RB, Przyrembel H, Borst P.
    J Clin Invest; 1987 Feb; 79(2):344-50. PubMed ID: 3805272
    [Abstract] [Full Text] [Related]

  • 2. Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients.
    Sturk A, Schaap MC, Prins A, ten Cate JW, Govaerts LC, Wanders RJ, Heymans HS, Schutgens RB.
    Blood; 1987 Aug; 70(2):460-3. PubMed ID: 3607283
    [Abstract] [Full Text] [Related]

  • 3. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y.
    Rinsho Byori; 1994 Jan; 42(1):63-9. PubMed ID: 8107285
    [Abstract] [Full Text] [Related]

  • 4. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F, Joseph D, Touqui L, Vargaftig BB.
    Thromb Haemost; 1985 Feb 18; 53(1):99-104. PubMed ID: 3992525
    [Abstract] [Full Text] [Related]

  • 5. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E, Ninio E, Beaurain G, Tence M, Niaudet P, Benveniste J.
    J Immunol; 1984 Aug 18; 133(2):892-8. PubMed ID: 6736649
    [Abstract] [Full Text] [Related]

  • 6. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
    Wang XD, Bian RL.
    Zhongguo Yao Li Xue Bao; 1990 Nov 18; 11(6):524-7. PubMed ID: 2130617
    [Abstract] [Full Text] [Related]

  • 7. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB, Joseph D, Marlas G, Chevance LG.
    Thromb Haemost; 1982 Aug 24; 48(1):67-71. PubMed ID: 7135345
    [Abstract] [Full Text] [Related]

  • 8. Measurement of ionized cytoplasmic calcium mobilization with the photoprotein aequorin in human polymorphonuclear leukocytes activated by platelet activating factor (PAF).
    Del Maschio A, Albors M, Evangelista V, Bucchi F, Bertelé V, Cerletti C, de Gaetano G.
    J Lipid Mediat; 1989 Aug 24; 1(1):25-36. PubMed ID: 2562430
    [Abstract] [Full Text] [Related]

  • 9. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI, Muzya GI.
    Biochemistry (Mosc); 2000 Apr 24; 65(4):427-30. PubMed ID: 10810178
    [Abstract] [Full Text] [Related]

  • 10. Endothelial cell associated platelet-activating factor (PAF), a costimulatory intermediate in TNF-alpha-induced H2O2 release by adherent neutrophil leukocytes.
    von Asmuth EJ, Buurman WA.
    J Immunol; 1995 Feb 01; 154(3):1383-90. PubMed ID: 7529802
    [Abstract] [Full Text] [Related]

  • 11. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
    Hornby EJ, Perry CR.
    Thromb Haemost; 1983 Aug 30; 50(2):586-7. PubMed ID: 6636035
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids.
    Sturk A, Schaap MC, Prins A, ten Cate JW, van den Bosch H.
    Biochim Biophys Acta; 1989 Dec 08; 993(2-3):148-56. PubMed ID: 2512985
    [Abstract] [Full Text] [Related]

  • 13. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M, Zhang LZ, Lu JS.
    Zhongguo Yao Li Xue Bao; 1995 May 08; 16(3):209-12. PubMed ID: 7660812
    [Abstract] [Full Text] [Related]

  • 14. Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets.
    Ito S, Camussi G, Tetta C, Milgrom F, Andres G.
    Lab Invest; 1984 Aug 08; 51(2):148-61. PubMed ID: 6379289
    [Abstract] [Full Text] [Related]

  • 15. [Platelet aggregation and platelet activating factor (author's transl)].
    Chignard M, Vargaftig BB, Benveniste J, Le Couedic JP.
    J Pharmacol; 1980 Aug 08; 11(4):371-7. PubMed ID: 7206730
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
    Bussolati B, Mariano F, Cignetti A, Guarini A, Cambi V, Foà R, Piccoli G, Camussi G.
    J Immunol; 1998 Aug 01; 161(3):1493-500. PubMed ID: 9686616
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C, Maiolo A, Tua A, Grignani G.
    Haematologica; 2000 Aug 01; 85(8):820-5. PubMed ID: 10942928
    [Abstract] [Full Text] [Related]

  • 20. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
    Oda M, Satouchi K, Yasunaga K, Saito K.
    J Immunol; 1985 Feb 01; 134(2):1090-3. PubMed ID: 3917470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.